Q3 FY2024 · Interim report
Novo Nordisk - Q3 2024 London Conference Call - Report · 34 pages
Read Novo Nordisk A/S Class B's results firsthand
Preview the first 2 pages of this interim report
Create a free account to start reading
Full documents are included with Professional
